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Nine female runners and ten walkers completed a 60min moderate-intensity (70% VO2max) run or walk, or 60min rest in
counterbalanced order. Plasma concentrations of the orexogenic peptide ghrelin, anorexogenic peptides peptide YY (PYY),
glucagon-like peptide-1 (GLP-1), and appetite ratings were measured at 30min interval for 120min, followed by a free-choice
meal.Bothorexogenicandanorexogenicpeptideswereelevatedafterrunning,butnochangeswereobservedafterwalking.Relative
energy intake (adjusted for cost of exercise/rest) was negative in the meal following running (−194 ± 206kcal) versus walking
(41 ±196kcal) (P = 0.015), although both were suppressed (P<0.05) compared to rest (299±308 and 284±121kcal, resp.). The
average rate of change in PYY and GLP-1 over time predicted appetite in runners, but only the change in GLP-1 predicted hunger
(P = 0.05) in walkers. Results provide evidence that exercise-induced alterations in appetite are likely driven by complex changes
in appetite-regulating hormones rather than change in a single gut peptide.
1.Introduction
The beneﬁts of exercise in the prevention of chronic diseases
including overweight and obesity are well documented. Reg-
ular physical activity reduces blood pressure, creates a more
favorable lipid proﬁle, and reduces risk for stroke, coronary
heart disease, hypertension, and colon cancer [1, 2]. Regular
exercisealsohelpsmaintainhealthybodyweight[1]andma y
aid in weight loss and weight loss maintenance [3]. To help
prevent weight gain (or obesity), the 2008 Physical Activity
Guidelines for Americans [4], sponsored by the Centers
for Disease Control and Prevention and Healthy People
2020, suggests incorporating a minimum weekly total of two
and a half hours of moderate-to-vigorous intensity physical
activity, spread over most days of the week. Working up to
ﬁ v eo rm o r eh o u r sp e rw e e k( ∼60min/day) is recommended
to gain additional beneﬁts which include weight loss and
weight loss maintenance.
Although the aforementioned recommendations, if fol-
lowed, are likely to have a major impact on health, inter-
vention studies ﬁnd that exercise without intentional food
restriction and/or behavior modiﬁcation does not eﬀectively
promote weight loss, [5, 6], particularly in women [7, 8].
Thismaybebecauseexercisestimulatesacompensatory(rel-
ative to the energy expenditure of the activity) or noncom-
pensatory drive to eat that is either biologically—(i.e., alter-
ed appetite regulating hormones) or psychologically—(i.e.,
feeling one deserves dessert after exercising) driven. These
studies, however, are not consistent with short-term exper-
imental studies conducted mostly in men which have found
reductions in appetite and relative food intake following
moderately intense-to-vigorous exercise. This may be be-
cause the exercise-induced eﬀect is inﬂuenced by factors in-
cluding the intensity and mode of the exercise [9–11], the
sex, and body composition of the exerciser [9, 10]. Several
previous studies found that hunger and/or food intake are2 Journal of Obesity
suppressed following 30–90min of intense- but not neces-
sarily light-to-moderate intensity exercise [12–18] including
cycling, running, and brisk walking. Others reported in-
creases in hunger and food intake following swimming [19]
and exercise calisthenics [20]. Less is known concerning
individual diﬀerences; however, one study found suppressed
hunger and food intake in lean but not overweight women
following bicycle exercise [21].
The recent discovery of several gut peptides involved in
appetite regulation and energy homeostasis provides an at-
tractive mechanism to explain how exercise reduces hung-
er/appetite in some conditions and increases it in others. Al-
terations in circulating ghrelin, the only known orexigenic
gutpeptide,alongwiththeanorexigenicgutpeptidespeptide
YY (PYY) and glucagon-like peptide-1 (GLP-1) may work in
concert to inﬂuence exercise-associated alterations in hunger
and food intake. Alterations in circulating gut peptides ap-
pear to regulate food intake for as long as 24h and are not
speciﬁcally controlled by body fat stores. A number of previ-
ous studies have found that these peptides are altered by an
acute bout of exercise [16, 17, 22–28]; however, the majority
of studies evaluated only a single mode of exercise compared
torest.Inaddition,onlyafewofthesestudiessimultaneously
evaluatedboththeorexogenicandanorexogenicgutpeptides
[17, 27, 28], and few included women [23, 27, 28].
The purpose of this study was to assess the eﬀect of a
60-minute bout of exercise on circulating concentrations of
gut peptides ghrelin, PYY, and GLP-1; appetite and ad libi-
tum food intake among women. An additional purpose was
to assess whether alterations in these gut peptides were as-
sociated with alterations in appetite following exercise. Exer-
cise was performed at a moderately hard intensity in two dif-
ferent modes: running and walking. We hypothesized that
circulating ghrelin would be suppressed; PYY and GLP-1
concentrations elevated following both modes of exercise
compared to rest. Furthermore, we hypothesized that ghrelin
concentration would be directly correlated with ratings of
hunger and desire to eat and PYY and GLP-1 concentrations
would be indirectly correlated.
2. Methods
Nine endurance-trained female runners and ten habitual
walkers between the ages of 18–40 were recruited for the
study. To qualify, participants had to be in good general
health, have normal hemoglobin (between 14.0–18.0mg/dL)
and thyroid status (thyroid stimulating hormone between
0.40–4.50mlU/L),haveregularlyoccurringmenstrualcycles,
and be of “low exercise risk” as per the American College of
Sports Medicine (ACSM) [29] .T h er u n n e r sh a dt ob ec u r -
rently running at least 32km/wk, be performing runs of at
least 60min in duration as part of their training regiment,
and have maximal aerobic capacity (VO2max) of at least
45mL/kg/min. The walkers had to be performing walks of
at least 60min in duration three or more days/wk and have
aV O 2max of less than 40mL/kg/min. Participants were exc-
luded if they smoked, were anemic, hyper-or hypo-thyroid,
pregnant or postmenopausal, had renal, hepatic, endocrine,
gastrointestinal, pulmonary, cardiac, or hematological dis-
eases including high blood pressure (>120/80mm/Hg at
rest), prediabetes/diabetes, demonstrated signs of signiﬁcant
depression, anxiety, other psychological problems, alcohol-
ism or other substance abuse, used prescription or over the
counter medications (other than contraceptives), or herbal
preparations that can inﬂuence metabolism, had food aller-
gies, or were unwilling to consume all foods/beverages pro-
vided in the run-in diet. The study was approved by the In-
stitutional Review Board of the University of Wyoming. Vol-
unteerswerefullyinformedofpossiblerisksofallprocedures
before providing written informed consent.
2.1. Baseline Testing. Approximately two weeks before initi-
ation of the experimental protocol, VO2max was determined
on a motor-driven treadmill (Trackmaster TMX22, Newton,
KS, USA) in accordance with ACSM recommendations [29].
For most runners, testing was initiated at 6mph (0% grade)
with the grade increasing by 1% every min until exhaustion.
For the walkers, the test was initiated at 3.5mph (2% grade)
with grade increasing by 1% every min until exhaustion.
Oxygen consumption (VO2) and carbon dioxide production
(VCO2) were measured continuously using a metabolic cart
(ParvoMedics TureOne 2400, Sandy, UT, USA), and heart
rate(HR)wasmonitoredbyanelectrocardiographymachine
(Quinton Q-5000, Bothell, WA, USA). Rating of perceived
exertion (RPE) was assessed during the last 10 seconds of
each stage using the modiﬁed Borg Scale [29]. The highest
20-second VO2 and respiratory exchange ratio (RER) achie-
vedintheﬁnaltwominofexercisewererecordedasthemax-
imum values. To qualify as an acceptable maximum test, par-
ticipants had to meet two of the four following criteria:
(1) a leveling or plateau of VO2 (deﬁned as an increase of
<2mL·kg−1·min−1 with increased workload); (2) RER ≥
1.10; (3) maximum heart rate within 10 beats of age pre-
dicted maximum [208 − (0.7 × age)] [30]; (4) rating of per-
ceived exertion (RPE) ≥ 17. After a 30min recovery period,
participants underwentatitrationrun/walktodetermine the
speed and grade required to elicit an oxygen uptake of 70%
VO2max. For descriptive purposes, body composition was
measured using dual-energy X-ray absorptiometry (DEXA,
GE Lunar Prodigy 8743, Waukesha, WI, USA).
2.2.ExperimentalProtocol. Thestudywasacounterbalanced,
cross-over study where participants completed an exercise
and control (rest) test day. A schematic of the study is shown
in Figure 1. The two test trials were scheduled in the fol-
licular phase of the participants’ menstrual cycle (between
days 1 and 11) and spaced either 2 to 10 days or 1 menstrual
cycle (3 to 5 wks) apart. The exercise test day consisted of
a 60min run/walk at 70% VO2max followed by 2h of rest,
whereas the control day consisted of 3h of rest. Food intake
wascontrolledfor24hpriortoeachtestdaybyprovidingpa-
rticipants with a controlled diet. The diet provided 2000kcal
(64% carbohydrate, 14% protein, and 22% fat) from com-
mercially available foods and beverages plus an optional ad-
ditional 200kcal provided as two 100kcal snack bars (28.4g,
∼100kcals; Clif Bar and Company, Berkeley, CA, USA).Journal of Obesity 3
19 females
Runners n = 9
Walkers n = 10
Exercise day Control day
• Follicular phase of menstrual cycle
￿ Standard breakfast 120 min before
￿ Pre-exercise blood draw
￿ 60-min run/walk @ 70%  max
￿ Blood draws every 30 min for 2 h
￿ Hunger ratings prior to blood draws
￿ Ad libitum meal 2 h after exercise
￿ Follicular phase of menstrual cycle
￿ Standard breakfast 120 min before
￿ Prerest blood draw
￿ 60 min rest (30 min resting metabolic
rate via indirect calorimetry)
￿ Blood draws every 30 min for 2 h
￿ Hunger ratings prior to blood draws
￿ Ad libitum meal 2 h after rest
VO2
Figure 1: Schematic of the counter-balanced cross-over study.
V o l u n t e e r sw e r ea s k e dt oc o n s u m et h ef o o d sp r o v i d e d( a n d
nothing in addition other than water) and to return empty
wrappers and any food and beverages that could not be
consumed.
2.3. Test Days. On both test days, participants consumed a
standard breakfast (Boost Smoothie, Clif Builder Bar and 2
cups of water; ∼380kcal; 65% carbohydrate, 20% protein,
15% fat) at 0630 prior to arriving in the laboratory. At 0730,
height, weight, and blood pressure were measured. On the
control visit, an intravenous indwelling (IV) catheter was
inserted into an arm or hand vein and connected to a normal
saline solution (0.9% saline solution) that was slowly infused
to keep the catheter patent. Blood was drawn immediately
before (baseline, preexercise) and immediately after one h of
rest (t = 0min) and every 30min thereafter for 2h (t =
30, 60, 90, 120min). The ﬁrst 3cc at each time point draw
was presumed to be diluted with saline and was discarded.
Resting energy expenditure (REE) and respiratory quotient
(RQ) were measured using a metabolic cart (160 lpm pneu-
matach,ParvoMedics,TrueOne2400,Sandy,UT,USA)while
the subject lay motionless in the supine position, as previ-
ously described [31]. The last 20min of data was used to cal-
culate REE.
On the exercise day, baseline blood was obtained by
venipuncture. An IV catheter was inserted immediately fol-
lowing the 60min run/walk, and blood was drawn on the
same schedule as the rest day. For 10min at the beginning
(between 5–15min afterthe start) and end (last 5min) of the
run/walk session, VO2,V C O 2,R E Ra n dR P E ,w e r em e a s u r e d
using a metabolic cart (800 lpm pneumatach, ParvoMedics,
TrueOne 2400, Sandy, UT, USA). Exercise pace was adjusted,
if necessary, during the ﬁrst 10min to achieve an oxygen cost
as close to 70% VO2max as possible but was not further ad-
justed. HR was monitored continuously using a portable
heart rate monitor (Polar S60i, Polar, Port Washington, NY,
USA).
On both test days, hunger and satiety were assessed using
100mm visual analogue scales (VASs), anchored at each end
with a word describing the extremes of the appetite being
measured [32]. The scales speciﬁcally asked (1) how hungry
doyoufeel?(2)howsatisﬁeddoyoufeel?;(3)howfulldoyou
feel? (4) how much do you think you can eat? Hunger and
satiety ratings were obtained 4 to 5min before each blood
draw(t = 0,30,60,90,and120)andat20minafterinitiation
of the ad libitum meal (see below).
At completion of the exercise and rest sessions (120min),
participantswereoﬀeredanadlibitum,free-choicemeal.The
free-choice meal consisted of the following (in weighed por-
tions) attractively and consistently arranged on the dining
table: rigatoni pasta (140g dry, cooked), marinara sauce
(140g), alfredo sauce (140g), whole-wheat bread (2 slices),
white bread (2 slices), hard boiled eggs (2), apples (2), or-
anges (2), Clif snack bar (2), Clif Builder bar (2), nonfat
yogurt (1, 6oz), regular yogurt (1, 6oz), individual portions
of margarine (4), honey (4), peanut butter (4), assorted jel-
lies (4), lemon-lime Gatorade (2, 20oz), 2% milk (2, 8oz),
and water (∼1500g). Participants were given 20min to eat
the meal and were instructed to eat until satiety. Participants
were not allowed to read or study during the meal or carry
backpacks, purses, or coats into the room. They were dis-
cretely monitored by the same investigator who worked qui-
etly on a computer in the back of the room (with their back
turned toward the participant). Food and water consump-
tion were determined by weighing remaining food (to the
nearest 0.1g) at cessation of eating. By diﬀerence, food/be-
veragesconsumedwereanalyzedfortotalenergy,protein,fat,
carbohydrate, simple sugars, and ﬁber using Nutritionist Pro
(Axxya Systems, Staﬀord, TX, USA, 77477). Ad libitum wa-
ter intake and intake of energy and macronutrients as solids
and liquids were also assessed. Relative food intake was cal-
culated by subtracting estimated energy expenditure during
the exercise (60min exercise, 120min rest) or rest (180min
rest) sessions from the respective free-choice energy intake.
2.4. Blood Samples and Hormone Analysis. Blood samples
taken both before exercise and rest (baseline) were analyzed
for serum concentrations of progesterone concentration4 Journal of Obesity
using a human solid phase RIA kit (Siemens Diagnostics, Los
Angeles, CA, USA). Plasma samples were analyzed for total
ghrelin, acylated ghrelin (ghrelinacyl), PYY3-36,G L P - 1 ,g l u -
cose, lactate and hematocrit at pre-exercise/rest and for
120min following exercise and rest were analyzed for total
ghrelin, acylated ghrelin (ghrelinacyl), PYY3-36,G L P - 1 ,g l u -
cose,lactate,andhematocrit.Bloodsamplesfortotalghrelin,
ghrelinacyl, PYY3-36, and GLP-1 were collected into EDTA-
treated prechilled tubes. Blood collected for analysis of plas-
ma ghrelinacyl was collected into a chilled tube containing
100µL of 200mM AEBSF with 200µLo f1NH C la d d e dp e r
mL of plasma following centrifugation. Samples collectedfor
analysis of PYY were treated with 150µL of aprotinin and
40µL DPP-IV. All plasma samples were cold-centrifuged (2–
8◦C) for 10min at 3500rpm. Aliquots of supernatant were
stored in cryovials at −80◦C and batch-analyzed in duplicate
at study completion by radioimmunoassay using commerc-
iallyavailablekitsspeciﬁcforhumans(Millipore,St.Charles,
MO, USA). Blood samples for analysis of glucose and lactate
were collected into 4mL purple top vacutainers, centrifuged
as above, and the plasma was stored at −80◦C until analysis.
Glucose and lactate were analyzed using a Microstat Multi-
assay Analyzer (Analox instruments, Lunenburg, MA, USA).
Hematocrit was analyzed as a marker of hemoconcentration
and hemodilution using an Autocrit Ultra 3 (Clay Adams,
Sparks, MI, USA) at each blood draw.
2.5. Statistical Approach. A sample size analysis conducted
with mean and standard deviation estimates based on pre-
liminary exercise-associated data from Russel et al. [28]i n
women (n = 10) and Martins et al. [33]i nb o t hs e x e s
(n = 6 men, 6 women) for the pre-to post-exercise change in
PYY3-36 (15 to 25% increase with exercise; SDs proportional
to means; ratio of SD to mean = 0.26) and an alpha = 0.05
determined that a sample size of n = 8w a ss u ﬃcient to de-
tect, with 80% power, a minimal postexercise increase of
∼20% (http://www.statsalive.com/). Given this calculation,
an n = 9 for each exercise group (i.e., one additional subject
per group) was selected. The sample size calculation was not
performed using ghrelin or ghrelinacyl due to inconsistent re-
sults for ghrelin and lack of published results for ghrelinacyl.
Our ﬁrst aim was to assess the eﬀect of exercise on cir-
culating concentrations of gut peptides, appetite, and ad libi-
tum food intake among runners and among walkers. Con-
centrations of the gut peptides (total ghrelin, ghrelinacyl;
PYY3-36 and GLP-1), and the primary measure of appetite,
hunger ratings were measured at baseline and ﬁve time
points (t = 0, 30, 60, 90, and 120 minutes) following exer-
cise and rest. As secondary outcomes relating to appetite, we
also considered ratings of satiety, fullness, and desire to eat.
For each subject, we summarized the repeated measures by
calculating the slope or the rate of change in outcome per
30-minute interval, following exercise and rest. Using the
derived slopes as the outcome, linear regression models were
ﬁt to evaluate diﬀerences between exercise and rest responses
over the entire period of 120 minutes following exercise or
rest. We adjusted for baseline levels and included an inter-
action between exercise/rest and runner/walker group. We
calculated robust standard errors that accounted for corre-
lation between exercise and rest measures from the same
subject. As a way of capturing total response over all time
points, the area under the curve (AUC) was also calcula-
ted for the 120 minutes following exercise and rest for the
gut peptide concentrations and hunger ratings using the
trapezoid method (GraphPad Prism version 5.02 for Win-
dows, GraphPad Software, San Diego, CA, USA, http://www
.graphpad.com/). AUC included, by deﬁnition, the area un-
der the curve and above baseline. For ghrelin, ghrelinacyl,
and GLP-1 which were observed to dip below baseline in the
later postexercise period, negative AUC was also calculated
as the area above the curve and below baseline. Paired t-tests
were used to evaluate diﬀerences between exercise and rest
responses over the entire period of 120 minutes after exercise
or rest, within runners and within walkers. Ad libitum food
intake was measured at a single time point following the ad
libitum meal, as absolute energy intake and relative energy
intake. Again, paired t-tests were used to compare exercise
versus rest within runners and within walkers. As secondary
outcomes, we also considered more speciﬁc components of
energy intake, using three macronutrients: protein, carbohy-
drate, and fat. As an exploratory analysis relating to this aim,
we also assessed the immediate eﬀects of exercise versus rest
on gut peptide concentrations and appetite. That is, rather
than considering the trajectory of each outcome across all
time points from t = 0t ot = 120, we considered only the
diﬀerence between the measurements at t = 0 and at base-
line for exercise versus rest. With these diﬀerences as the out-
comes, we ﬁt linear regression models, including an interac-
tion between exercise/rest and runner/walker group. Again,
we calculated robust standard errors that accounted for cor-
relation between exercise and rest measures from the same
subject.
Our second aim was to investigate whether changes in
ghrelin, ghrelinacyl, PYY, and GLP-1 were associated with
changes in hunger following exercise. For each gut peptide,
we ﬁt a linear regression model with the peptide concentra-
tion as the predictor of interest and hunger as the outcome.
Additionally, we included an interaction between hormone
levelandrunner/walkergroupandadjustedforbaselinehun-
ger rating and exercise/rest period. Again, we calculated rob-
ust standard errors to account for multiple measures from
the same subject. The other appetite ratings were also asses-
sed as secondary outcomes. Statistical analyses were perfor-
med using Stata (version 10) and R statistical software (ver-
sion 2.10.1). All reported P values were two-sided, with
statistical signiﬁcance taken to be P value < 0.05. There was
no adjustment for multiple testing.
3. Results
Nineteen volunteers (9 runners and 10 walkers) enrolled in
the study. The majority of the runners regularly competed
in local road races and two were NCAA division I collegiate
runners. The walkers walked regularly either for ﬁtness and
weight control, or as cross-training for other activities. None
of the walkers, however, were regular runners or joggers.Journal of Obesity 5
Table 1: Baseline preexercise characteristics for 9 female runners and 10 female walkers. Data are presented as mean ± SD. Body fat
percentage by dual-energy X-ray absorptiometry; VO2max: maximal oxygen uptake while running or walking on a motor driven treadmill.
(a) Anthropometric characteristics
Runners Walkers P value
Age (yr) 23.7 ±2.42 4 .6 ±6.90 . 7 0
Height (cm) 163.9 ±4.2 164.6 ±8.60 . 8 0
Mass (kg) 53.5 ±3.16 0 .0 ±12.30 . 1 4
BMI (kg·m−1)1 9 .8 ±1.02 2 .1 ±3.40 . 0 6
Body Fat (%) 23.0 ±4.93 5 .7 ±5.2 <0.001
VO2max (mL·kg−1min−1)4 9 .7 ±3.03 3 .9 ±3.7 <0.001
(b) Gut peptide concentrations and appetite ratings before exercise and rest trials
Runners Walkers
Exercise∗ Rest∗ P value† Exercise∗ Rest∗ P value†
Ghrelin 144.7 ±52.6 167.8 ±37.0 0.33 126.8 ±42.8 209.4 ±127.80 . 0 9
Ghrelinacyl 10.6 ±8.62 5 .4 ±15.70 . 0 2 6 .4 ±2.81 5 .2 ±7.20 . 2 2
PYY 45.0 ±8.94 3 .6 ±10.90 . 6 75 1 .2 ±16.64 5 .9 ±13.60 . 3 9
GLP-1 42.5 ±19.54 7 .6 ±15.50 . 5 9 5 5 .2 ±9.65 0 .9 ±27.00 . 6 3
Hunger 8.9 ±9.41 3 .6 ±16.40 . 3 4 7 .5 ±9.71 7 .7 ±28.30 . 2 3
Satiety 71.8 ±23.27 7 .7 ±19.30 . 7 57 9 .6 ±20.26 6 .0 ±28.90 . 1 1
Fullness 64.6 ±26.47 8 .2 ±15.60 . 2 98 4 .2 ±11.47 3 .6 ±26.70 . 2 0
Desire to Eat 26.6 ±25.13 3 .4 ±30.10 . 5 11 8 .4 ±14.23 2 .4 ±27.80 . 0 4
∗Mean ± SD.
†Based on paired t-test.
Data from blood samples are missing for several participants
at one or more time points following the exercise or rest
periods due to complications from obtaining blood via
the indwelling catheter (i.e., occasional clotting inadequate
venous return). Data for ghrelinacyl are missing for several
time points due to undetectable readings by the RIA.
3.1. Baseline Characteristics. The characteristics of the 9
runnersand10walkersaresummarizedinTable 1.Table 1(a)
shows that the exercise groups were fairly comparable with
respect to age and height. Not surprisingly, the runners were
leaner than the walkers and had a higher VO2max than the
walkers.
Comparing exercise versus rest, Table 1(b) and Figure 3
s h o wu n e x p e c t e dd i ﬀerences at baseline (preexercise or rest)
in mean Ghrelinacyl only among runners, whereas mean ghr-
elin, PYY, and GLP-1 were similar in both groups before
exercise and rest periods. Diﬀerences in mean appetite ra-
tings were also observed prior to exercise versus rest periods
among both runners and walkers.
The energy and macronutrient intakes of the controlled
diet were similar (P>0.05) before exercise and rest in both
the runner and walker groups. Runners averaged 1868 ±
380kcal (14.1±1.7% protein, 64.8±3.2% carbohydrate, and
21.4±2.3%fat)beforeexerciseand 2035±239kcal(14±0.6%
protein, 63.6 ± 1.3% carbohydrate, and 22.4 ± 1.1% fat)
before rest. Walkers averaged 1770 ± 400kcal (14.7 ± 1.5%
protein, 63.8 ± 2.7% carbohydrate, and 21.5 ± 2.6% fat)
before exercise and 1811 ± 357kcal (14.9 ± 1.8% protein,
62.3 ± 1.8% carbohydrate, and 22.7 ± 1.5% fat) before rest.
In the runners, the exercise test day fell on menstrual cycle
day 5.9±3.1, whereas the rest day fell on day 5.2±2.9. In the
walkers, exercise and rest days fell on 5.4 ± 3.4a n d4 .4 ±1.5,
respectively. Serum progesterone concentrations were less
than 2ng/mL for all participants during both exercise and
rest and averaged 0.66 ± 0.2a n d0 .64 ± 0.19 for runners and
0.63±0.33and0.46±0.3forwalkersduringexerciseandrest,
respectively, conﬁrming follicular status.
3.2. Oxygen Uptake, Heart Rate and Energy Expenditure. Ab-
soluteVO2,HR,RER,RQ,RPE,andenergyexpenditure(EE)
during the 60min bout of running or walking and rest along
with concentrations of lactate and glucose are shown in
Table 2. Runners ran at an average pace of 2.9 ± 0.18m/s
(6.5MPH),andwalkerswalkedatanaverageof1.69±0.1m/s
(3.77MPH). Absolute VO2 was higher during exercise
in runners versus walkers, but relative VO2 was similar (P =
0.624) and averaged 70.4 ± 4.1% and 68.6 ± 6.4% VO2max
during the run and walk, respectively. HR was also ∼10bpm
higher during exercise in the runners compared to the walk-
ers (172bpm versus 162bpm) but was similar between the
rest trials. Energy expenditure was approximately 180kcals
higher during exercise in runners compared to walkers
(483.1kcal/h versus 305.1kcal/h) but was similar at rest.
Blood lactate concentration was also similarly elevated fol-
lowing the run and the walk.6 Journal of Obesity
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Figure 2: Average hematocrit for runners and walkers during exercise (solid grey) and rest (dashed black). “Pre” represents the time point
just before exercise or rest. Vertical bars display the standard error of the mean hematocrit concentration at that time point.
Table 2: Oxygen uptake, energy expenditure, and heart rate of 9 female runners and 10 female walkers during 60min of exercise and 60min
of bed rest. VO2: volume of oxygen uptake; RER: respiratory exchange ration; RQ: respiratory quotient; HR: heart rate; RPE: rating of
perceived exertion.
Rest Exercise
Runners∗ Walkers∗ Runners∗ Walkers∗ RunnersEx versus
walkersEx
† P value
VO2 (L·min−1)0 .23 ±0.02 0.22 ±0.04 1.9 ±0.16 1.39 ±0.34 0.48 (0.22, 0.73) 0.001
RER/RQ 0.78 ±0.05 0.74 ±0.05 0.90 ±0.03 0.88 ±0.04 −0.01 (−0.04, 0.02) 0.570
Energy expenditure (kcal/h) 65.5 ±6.76 2 .3 ±11.5 483.1 ±49.7 324.6 ±138.1 158.5 (56.2, 260.7) 0.01
HR (bpm) 68.6 ±24.37 2 .3 ± 7.9 171.8 ±11.3 161.9 ±16.19 . 9 ( −4.17, 24.0) 0.15
RPE — — 13.1 ±1.11 4 .1 ±2.7 −0.97 (−3.13, 1.19) 0.35
Lactate (mmol/L) 0.76 ±0.26 0.92 ± 0.41 .4 ±0.66 1.0 ±0.55 0.4 (−0.21, 1.0) 0.19
Glucose (mmol/L) 5.1 ±0.56 5.0 ±0.67 6.7 ±1.85 .7 ±0.66 1.03 (−0.38, 2.4) 0.14
∗Mean ± SD.
†Diﬀerence in means (95% conﬁdence interval) from two-sample t-test.
VO2: oxygen uptake; RER: respiratory exchange ratio; RQ: respiratory quotient; HR: heart rate; RPE: rate of perceived exertion.
3.3. Blood Concentration, Hormones, and Metabolites
Blood Concentration. As shown in Figure 2,t o t a lh e m a t o c r i t
was fairly constant over time following both exercise and rest
in the runners and walkers. However, because hemoconcen-
tration was observed following exercise in quite a few of the
walkersandanoccasionaldilutesamplesfromsalineinfusion
was observed in both groups, blood data were adjusted ac-
cording to the methods of Dill and Costill [34] and used in
allstatisticalanalyses.Asasensitivityanalysis,werepeatedall
analyses using the unadjusted data and obtained similar
results (data not shown).
Ghrelin. Figure 3 (upper left panel) illustrates the average
trajectoryoveralltimepoints(onetimepointbeforeexercise
or rest and ﬁve time point after exercise or rest). Average to-
tal ghrelin concentration drifted upward immediately after
exercise in the runners and the walkers, and then leveled oﬀ
in the runners, while demonstrating large variability in the
walkers. The concentration remained fairly constant after
rest. Table 3(a) reﬂects these results, indicating that exercise
may increase the overall rate of change of ghrelin concentra-
tion in runners. While the rate of change after exercise stay
c l o s et oz e r o( −2.1pmol/L per minute), a positive averageJournal of Obesity 7
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Figure 3: Average change in ghrelin (pmol/L, upper left panel), ghrelinacyl (pmol/L, upper right panel), PYY (pmol/L, lower left panel), and
GLP-1 (pmol/L, lower right panel) for runners and walkers during exercise (solid grey) and rest (dashed black). “Pre” represents the time
point just before exercise or rest. Vertical bars display the standard error of the mean concentration of gut peptide at that time point.
postexercise slope (10.0pmol/L per 30 minutes) and an over-
all positive diﬀerence between exercise and rest (12.9pmol/L
per minute, 95% CI [−3.9, 29.7], P value = 0.12) are esti-
mated. Meanwhile, for walkers, the larger variability at later
timepointsmayobscurethetrueeﬀectofexercise.Table 3(b)
contains results of exploratory analysis relating to immediate
eﬀects of exercise. Figure 3 (upper right panel) shows pat-
ternsforaverageGhrelinacyl concentrationthataresomewhat
similar to those for total ghrelin. Table 3(a) shows little evi-
dence of an exercise eﬀect on the rate of change of Ghrelinacyl
concentration over time. There is some indication, however,
of a larger immediate increase in Ghrelinacyl concentration
after exercise versus after rest among runners (7.9pmol/L,
95% CI [−0.9, 16.7], P value = 0.075).
The positive AUC (area above baseline) for both total
ghrelin and ghrelinacyl was found to be higher following ex-
ercise in the runners but not the walkers. Negative AUC
(area under baseline) was found to be smaller following ex-
ercise. Together, these results indicated that total response as
measured by total ghrelin and ghrelinacyl tended to be higher
after exercise than after rest among runners (Table 4).
PYY and GLP-1. In runners, PYY concentration peaked im-
mediately after exercise (Figure 3) then gradually returned
to baseline over the 120min after exercise; whereas in wa-
lkers, PYY concentration peaked at 30min after exercise
before returning to baseline 90min after exercise. Table 3(a)
shows evidence of the eﬀect of exercise on the rate of cha-
nge of PYY, with exercise causing a faster decline in PYY con-
centration over time among runners (−2.0pmol/L per 30
minutes, 95% CI [−4.0, −0.095], P value = 0.041) and
among walkers (−6.7pmol/L per 30 minutes, 95% CI
[−13.2, −0.14], P value = 0.43), although the eﬀect was not
statistically signiﬁcant in the walkers potentially due to high
variability. Immediate eﬀects were also evident, but positive
(Table 3(b)), thus reﬂecting the observed pattern of an im-
mediate rise in concentration followed by a decline among
both runners and walkers. The positive AUC for PYY tended
to be higher after exercise versus rest in the runners. Negative
AUC was also found to be higher after exercise versus rest in
walkers (Table 4).
SimilartoPYY,GLP-1concentrationpeakedimmediately
after exercise in both runners and walkers returning to pre-
exercise concentrations at approximately 30min after exer-
cise. Unlike PYY, GLP-1 dipped visibly below baseline after
60min after exercise in both groups (Figure 3). Table 3(a)
shows fairly large eﬀects of exercise on the rate of change of
GLP-1. Again, exercise caused a faster decline in GLP-1
concentration among both runners (−10.7pmol/L per 30
minutes,95%CI[−17.0,−4.4],P value =0.002)andwalkers
(−16.5pmol/L per 30 minutes, 95% CI [−28.0, −5.0], P va-
lue = 0.008). There was evidence of an immediate eﬀect of
exercise among runners, but not in walkers. The positive
AUC for GLP-1 was not diﬀerent following exercise com-
pared to rest in either the runners or the walkers, however,Journal of Obesity 9
Table 4: Eﬀect of exercise on AUC values for hormones and metabolites. Results for both positive and negative AUC are presented.
Hormone/ Runners Walkers
metabolite Exercise∗ Rest∗ Exercise eﬀect† P
value
Exercise∗ Rest∗ Exercise eﬀect† P value
Ghrelin
(+) area 20641 ±16238 6322 ±6450 14319 (340, 28298) 0.05 18157 ±26247 6863 ±9390 11294 (−10486, 33075) 0.27
(−)a r e a 5672 ±16471 3908 ±7977 1764 (−12808, 16336) 0.79 6839 ±8708 24574 ±32687 −17734 (−44816, 9348) 0.17
Ghrelinacyl
(+) area 6246 ±4933 700 ±584 5546 (1822, 9271) 0.01 2067 ±2437 1345 ±1575 723 (−833, 2279) 0.32
(−)a r e a 105 ±183 1688 ±2184 −1583 (−3172, 6) 0.05 813 ±1671 946 ±1283 −133 (−1297, 1031) 0.80
PYY
(+) area 1796 ±2667 59 ±92 1737 (−290, 3764) 0.08 90 ±163 1073 ±2325 −983 (−2686, 719) 0.22
(−)a r e a 2575 ±2306 4211 ±3103 −1635 (−4678, 1407) 0.25 6912 ±6575 2415 ±1483 4497 (−502, 9496) 0.07
GLP-1
(+) area 1114 ±926 693 ±691 421 (−313, 1155) 0.22 556 ±650 656 ±618 −181 (−851, 488) 0.54
(−)a r e a 802 ±789 941 ±1154 −139 (−1273, 995) 0.78 1957 ±2058 1447 ±3459 1658 (4, 3311) 0.05
∗Mean ± SD of AUC.
†Diﬀerence in means (95% conﬁdence interval) from paired t-test.
Table 5: Eﬀect of exercise on absolute energy, relative energy, and macronutrient intake, among runners and among walkers.
Runners Walkers
Exercise∗ Rest∗ Exercise eﬀect† P value Exercise∗ Rest∗ Exercise eﬀect† P value
Absolute
energy intake
(kcals)
485.8 ±183.4 480.4 ±126.4 5.5
(−112.0, 122.9)
0.917 623.9 ±139.1 550.6 ±162.4 73.2
(−11.0, 157.5)
0.08
Relative
energy intake
(kcals)
−193.9 ± 205.8 283.8 ±120.6 −477.7
(−610.1, −345.3)
<0.001 126.8 ±195.8 366.0 ±183.6 −274.6
(−385.0, −164.3)
<0.001
Protein (g) 19.3 ±6.01 9 .3 ±4.7 −0.046
(−4.1, 4.1)
0.980 27.6 ±7.32 4 .2 ±9.5 3.4
(0.043, 6.8)
0.05
Carbohydrate
(g)
80.5 ±37.47 9 .0 ±20.9 1.5
(−20.6, 23.7)
0.877 88.6 ±28.58 3 .1 ±22.2 5.5
(−13.0, 24.0)
0.51
Fat (g) 11.0 ±3.51 1 .3 ±5.4 −0.38
(−4.3, 3.6)
0.830 19.2 ±5.81 5 .1 ±7.4 4.1
(2.2, 6.0)
0.001
∗Mean ± SD.
†Diﬀerence in means (95% conﬁdence interval) from paired t-test.
the area below baseline was greater in the walkers (1957 ±
2058 and 1447 ± 3459, P = 0.05) but not the runners after
exercise versus rest (Table 4).
3.4. Hunger and Satiety Ratings. As shown in Figure 4 (top
panel),ratingsof“hunger”increasedfrombaselineacrossthe
120min after exercise or after rest period in both the runners
and walkers during the exercise and rest trials. Similar results
were observed for desire to eat, that is, how much you think
you can eat (data not shown). Ratings of satiety (Figure 4,
bottom panel) and fullness (data not shown) tended to
decrease from baseline across the 120min after exercise or
after rest period in both groups during both trials. We see
from Table 5 that there was not enough evidence to show
an eﬀect of exercise on the rate of change over time for any
of the four subjective appetite ratings in either group. The
AUCs for the four appetite ratings were also not found to be
signiﬁcantly diﬀerent after exercise versus after rest for either
group.
3.5. Ad Libitum Food Intake. As shown in Table 5, there was
no evidence of a diﬀerence between absolute energy intake
and macronutrient intake at the free-choice meal following
running versus rest. However, absolute intake tended to be
higher following walking compared to rest (73.2kcals, 95%
CI [−11.0, 157.5], P value = 0.080). Interestingly, walkers
(but not runners) tended to consume more protein (in wal-
kers: 3.4g, 95% CI [0.043, 6.8], P value = 0.048) and fat
(in walkers: 4.1g, 95% CI [2.2, 6.0], P value = 0.001) follow-
ing exercise compared to rest (Figure 5).
3.6. Relative Energy Intake. After adjusting for the cost of ex-
ercise or rest, relative energy intake was lower following
exercise compared to rest in both groups (P 0.001). In10 Journal of Obesity
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Figure 4: Average change in hunger (upper panel) and satiety (lower panel) for runners and walkers during exercise (solid grey) and rest
(dashed black). “Pre” represents the time point just before exercise or rest. Vertical bars display the standard error of the mean for hunger
and satiety at that time point. Data for fullness and desire to eat are not shown.
runners,relativeenergyintakewas477.7kcalslower(95%CI
[−610.1, −345.3]) after exercise compared to after rest. The
diﬀerence was smaller in walkers, with after exercise being
274.6kcals lower (95% CI [−385.0, −164.3]) than after rest.
3.7. Gut Peptides and Appetite Ratings. In the runners, the
change in concentrations of PYY and GLP-1 was predictive
ofthechangeinhunger(Table 6).Analogousresultswereob-
tainedforsatiety,fullness,anddesiretoeat(datanotshown).
Increases in PYY and GLP-1 were positively associated with
satiety and fullness and negatively associated with hunger
and desire to eat. In the walkers, there may be some indi-
cation of an association between hunger ratings and Ghre-
linacyl (0.63 units, 95% CI [−0.19, 1.46], P value = 0.12) and
GLP-1 (0.095 units, 95% CI [−0.32, 0.028], P value = 0.095)
concentrations.
4. Discussion
The purpose of the current study was to evaluate the eﬀect of
60min of moderately hard running and walking at the sameJournal of Obesity 11
Table 6: Association of hormone concentrations with hunger ratings.
Hunger
Hormone (pmol/L)
Runners Walkers
Hormone eﬀect∗ P value Hormone eﬀect∗ P value
Ghrelin 0.038 (−0.066, 0.14) 0.45 0.033 (−0.022, 0.088) 0.22
Ghrelinacyl 0.077 (−0.23, 0.38) 0.60 0.63 (−0.19, 1.46) 0.12
PYY −1.02 (−1.52, −0.53) <0.001 −0.034 (−0.28, 0.21) 0.78
GLP-1 −0.36 (−0.62, −0.11) 0.008 −0.14 (−0.32, 0.028) 0.09
∗Estimate (95% conﬁdence interval) from linear regression, adjusting for exercise and baseline hunger.
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Figure 5: Absolute energy intake (AEI), relative energy intake
(REI), and energy expenditure (EE) for exercise and rest in runners
and walkers.
relativeintensity(i.e.,70%ofmaximaloxygenuptake)ongut
peptide concentrations, appetite, and food intake at a single
ad libitum meal oﬀered 2h after exercise in habitually active
women. Short-lived increases in circulating concentrations
of the anorexogenic peptides and a trend for an increase in
ghrelinacyl following exercise were apparent in the runners
but not the walkers. These alterations in circulating gut pe-
ptides were associated with lower relative energy intake after
exercise compared to rest which created a negative energy
deﬁcit in the runners but not walkers. Interestingly, the aver-
age rate of change in the anorexogenic peptides PYY and
GLP-1 but not the orexogenic peptide ghrelin over time was
found to predict hunger in runners but not walkers.
Ghrelinissecretedbyspecializedcellsinthestomachand
is currently the only known orexogenic peptide [35, 36]. Cir-
culating concentrations of ghrelin peak during fasting, drop
after a meal and are thought to be involved in hunger and
meal initiation [37]. Peripheral infusion of ghrelin increases
food intake in animals [38] and humans [39] through inter-
action with neuropeptide Y (NPY) and agouti-related pro-
tein (AgRP)-expressing neurons of the hypothalamic arcuate
nucleus (ARC) and/or inhibition of vagal-aﬀerent nerves
[40]. Although ghrelin is present in circulation in acylated
(ghrelinacyl) and desacyl forms, only ghrelinacyl is thought to
cross the blood-brain barrier and exert orexigenic eﬀects[35,
40]. Thus, measurement of ghrelinacyl, which accounts for
∼10% of circulating concentration, is important particularly
becauseghrelinacyl respondsmorerapidlytoglucoseinfusion
[41] and exercise [42].
Our ﬁnding that the total response (i.e., AUC) of both
total ghrelin and ghrelinacyl was elevated above rest following
running but not walking at the same relative intensity is in-
triguing. Previous studies have observed decreases [17, 22,
26, 43, 44], increases [24, 45]o rn oa l t e r a t i o n[ 18, 23, 27, 46]
in both total ghrelin and ghrelinacyl concentrations following
exercise, but these inconsistent ﬁndings may be due to the
intensity(orenergycost)oftheexerciseemployedand/orthe
sex of the exerciser. For example, total ghrelin wasnot altered
by 60min of submaximal cycling [27] but was increased fol-
lowing 3h of prolonged cycling [24]a n d∼2 to 2.5h of in-
tense running [28]. Ghrelinacyl was also found to increase at
a meal following treadmill walking in overweight women but
not men [11] but only when the energy lost through exercise
was not replaced. Overall, these results suggest that the en-
ergycostoftheexercise(whichwas∼38%higherduringrun-
ning versus walking) may promote increased ghrelin secre-
tion, perhaps more so in women. Coupled with our ﬁnding
that neither total ghrelin or ghrelinacyl correlated with hun-
ger, the results also suggests that ghrelin is not a large con-
tributor to postexercise food intake perhaps because the sig-
nal is dampened by increases in the anorexogenic peptides
over the same time point [28].
In contrast to ghrelin, peptide YY and GLP-1 are satiety
peptides which are secreted from the endocrine L cells of the
distal gastrointestinal tract in response to a mixed meal [47].
CirculatingconcentrationsofbothPYYandGLP-1arelowin
fastingandincreasefollowingmealingestion[48].Peripheral
infusion of both peptides at physiological concentrations
markedly decrease food intake in humans [49, 50]w h i c h
appearstobeadditivewheninfusedsimultaneously[51].The
action of PYY is thought to be via inhibition of NPY/AgRP
neurons and/or stimulation of vagal-aﬀerent nerves, whereas
theactionofGLP-1isthoughttobeviavagalmediation[37].
Both forms of PYY (PYY3-36 and PYY1-36)a n dG L P - 1a r e
thought to serve as satiety signals, regulating the termination
of individual meals [40].
Consistent with our ﬁndings, previous studies have
foundelevationsinbothPYY[25,27,52]andGLP -1[27,52]
following diﬀerent modes and intensities of exercise. A stud-
yb yU e d aa n dc o l l e a g u e s[ 16] found that postexercise eleva-
tion of PYY but not GLP-1 was dependent on exercise
intensity and was elevated to a greater extent following
30min of cycling at 75% compared to 50% VO2max. In
another study, Broom and colleagues [17] found elevated
PYY and suppressed hunger in the 2h after a 60min bout of12 Journal of Obesity
runningat69%VO2maxcomparedtobothrestanda90min
bout of resistance exercise. It is important to note, however,
thattheenergycostwas50%higherinthehigh-comparedto
the moderate intense cycling and ∼260% greater with the
running compared to the resistant training in the afore-
mentioned studies. Thus, our ﬁnding that both PYY and
GLP-1 were elevated immediately after running, and that
onlyPYYwaselevatedafterwalkingmayalsobeexplainedby
the greater energy cost of the run, which was ∼37% greater
than the walk. Interestingly, the average rate of change in
PYY and GLP-1 after the run, and the rate of change in
GLP-1 after the walk was signiﬁcantly greater relative to rest,
indicating an average downward trend following exercise,
particularly for GLP-1 which dipped below baseline in the
later postexercise period. While it is possible this dip in GLP-
1, which had a more negative AUC in walkers compared to
runners, at least partially accounted for the higher (less neg-
ative) relative intake in the walkers compared to the runners,
future research is needed to aﬃrm that such a role is causal.
Our results concerning ad libitum food intake following
exercise in women are in agreement with previous studies in
bothsexeswhichfoundeithernodiﬀerenceorslightlyhigher
absolute food intake after a bout of exercise compared to
a noexercise control, but signiﬁcantly lower relative energy
intake when accounting for the energy cost of exercise [12,
13, 53–55]. Interestingly, in these studies, relative energy in-
take was lowest (i.e., creating a more negative balance) when
exercise intensity was high, and when foods oﬀered in the
subsequent ad libitum meal were low in fat [13, 53, 54].
Imbeault and colleagues [15], for example, found lower rel-
ative energy intake after 34min of running at 75% VO2max
than after 72min of walking at 35% VO2max, which elicited
the same energy cost (∼485kcal). King and colleagues [12],
who were ﬁrst to introduce the concept of relative energy in-
take, have argued the greater relevance of relative rather than
absoluteenergyintakebecausehigherenergyintakewouldbe
an expected compensatory mechanism of increased energy
expenditure through increased physical activity. Thus, if
energy intake remains the same following exercise, as in the
current study, it can be considered equivalent to a suppres-
sion of appetite relative to the intake expected to compensate
for the exercise. Unfortunately, the majority of studies, in-
cluding the current study, have not measured energy intake
f o ral o n ge n o u g hp e r i o da f t e re x e r c i s et oe v a l u a t eh o wc o m -
pensation for negative energy balance occurs following dif-
ferent modes of exercise like running but not necessarily
walking. Total or partial compensation through altered
energy intake and reduced energy expenditure are possible
and likely, otherwise exercise would result in drastic reduc-
tions in body mass/body adiposity.
Although we did not ﬁnd signiﬁcant diﬀerences in per-
ceived hunger at any point following running or walking
compared to rest, small changes in hunger due to exercise ra-
ther than time (observed in the nonexercise control condi-
tion) may be diﬃcult to detect using available methodology.
Indeed, only about half of the studies in men using designs
similartoourshaveobserveddiﬀerencesinhungerusingVAS
[12, 14, 16, 17, 22, 23, 27, 53, 56], whereas very few studies in
womenhavedetectedexercise-associateddiﬀerences[55,57].
The lack of a strong exercise inﬂuence on appetite in all
studies may be because VAS are not sensitive enough to de-
tect small changes following exercise using sample sizes ty-
pically employed for exercise studies. It also may be that only
a small subset of subjects is in tune with biological hunger
cues and respond instead to other signals including time of
day or time past since the last meal. Mattes [58], for example,
observed that food intake often occurred when hunger was
low or had not changed acutely. In our studies we did ﬁnd,
however, that VAS track well with changes in both PYY and
G L P - 1i nr u n n e r sa n dt e n d e dt ot r a c kw i t hG L P - 1i nw a l k e r s
whichsuggestsarelationbetweenappetiteratingsandsatiety
peptides even if exercise-induced alterations in appetite were
not observed.
The current study used a unique complex modeling ap-
proachtoevaluatewhetherchangesinthegutpeptidestrack-
ed with or predict changes in hunger and/or ad libitum food
intake. Collectively, our ﬁndings suggest that changes in PYY
and GLP-1 over time tracked indirectly with changes in hun-
ger and desire to eat, and directly with changes in satiety. In-
terestingly, the change in either total ghrelin or ghrelinacyl
did not track with subjective ratings of hunger. This provides
additionalsupportforthehypothesisthatsignalsfromeleva-
ted concentrations of circulating ghrelin may be muted by
elevated concentrations of satiety peptides. Given that few
[16, 22, 25] previous studies have found clear associations
between gut peptide concentrations and appetite following
exercise, it is probable that exercise-induced alterations in
appetite are driven by complex changes in appetite-regula-
tinghormonesratherthanasinglegutpeptideinisolation.A
previous study by Martins and colleagues [27], for example,
observed an inverse temporal pattern between hunger and
both PYY and GLP-1 concentrations during 1h of exercise
but did not describe such a relation following exercise. In
contrast, Broom et al. [22] and Ueda et al. [16]o b s e r v e d
direct associations between the AUC for plasma ghrelinacyl
and hunger, and indirect association between the AUC for
GLP and postexercise energy intake. The discrepancy be-
tweentheﬁndingsandpublishedstudiesmaybeexplainedby
the diﬀerent exercise-induced patterns of gut peptide release.
In the current study, we elected to evaluate the eﬀect of
walkingandrunningonappetiteandguthormoneresponses
because both weight-bearing activities are recommended for
weight loss and weight loss maintenance. Walking, however,
is the most common exercise recommended [18] and, unlike
running, can be undertaken by the majority of the popula-
tion because it does not require the ﬁtness base or produce
the biomechanical stress of running. Our overall observation
that walking did not elicit the same negative energy balance
or increase in the satiety hormones as did running, yet pro-
moted a slightly higher postexercise fat and protein intake,
suggests that walking may create some challenges for long-
termweightlossunlessdietaryrestrictionisemployed.While
ourresultsappeartocontradictthoseofKing andColleagues
[18] who observed signiﬁcantly lower relative energy intakes
in men after a 60-min “brisk” walk at a self-selected pace
(ranging from 33.8 to 55.5% VO2max), the apparently dis-
crepant results may help explain why exercise is less eﬀective
in promoting weight loss in women compared to men [7, 8].Journal of Obesity 13
The mechanism, however, may not be easily identiﬁed be-
cause Ghrelinacyl was not altered by walking in either study,
and King and colleagues [18] unfortunately did not simulta-
neously measure PYY, GLP or other satiety peptides. In our
study, we also observed a curious tendency for Ghrelinacyl,
total ghrelin and subjective hunger to be lower when subjects
knew that they were going to exercise, which may have inter-
fered with our ability to detect true changes with exercise
compared to rest. The increased consumption of fat may be
important given that a reversal of the energy deﬁcit induced
by previous exercise is noted when high-fat rather than low-
fat foods oﬀered after exercise [13, 53, 54]. Finally, from our
study design, it is impossible to determine whether our ob-
served diﬀerences between running and walking are due to
exercise mode or the physiological characteristics of the wal-
kers who were on average fatter and had a lower VO2max
(i.e., were less ﬁt) then the runners. Although the current
study did not measure any long-acting adiposity hormone
such as leptin or insulin, it is possible that these hormones
were higher in the walkers. Emerging evidence suggests that
long- and short-acting signals interact to alter hypothalamic
sensitivitytosatiationsignals[37]whichcouldultimatelyin-
ﬂuence eating behavior following exercise. Future studies
should consider diﬀerent modes of exercise along with sex
and adiposity diﬀerences of the exerciser and measurement
of short- and long-acting satiety signals.
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